Search bioRxivSearch

Biology subjects

Holmes, C. C.

Publications and source records attributed to Holmes, C. C..

3 recordsLinked to original sources

Machine learning for randomised controlled trials: identifying treatment effect heterogeneity with strict control of type I error

BackgroundIt is widely acknowledged that retrospective exploratory analyses of randomised controlled trials (RCTs) seeking to identify treatment effect heterogeneity (TEH) are prone to bias and false positives. Yet the increasing availability of multiple data modalities on subjects and the desire to learn all we can from trial participants motivates the inclusion of such analyses within RCTs. Coupled to this, widespread advances in AI and machine learning (ML) methods hold great potential to utilise such data to characterise subjects exhibiting heterogeneous treatment response.\n\nMethodsWe present new learning strategies for RCT ML discovery methods that ensure strict control of the false positive reporting rate at a pre-specified level. Our approach uses randomised data partitioning and statistical or ML based prediction on held-out data. This can test for both crossover and non-crossover TEH. The former is done via a two-sample hypothesis test measuring overall predictive performance of the ML method. The latter is done via stacking the ML predictors alongside a classical statistical model to formally test the added benefit of the ML algorithm. An adaptation of recent statistical theory allows for the construction of a valid aggregate p-value. This learning strategy is agnostic to the choice of ML method.\n\nResultsWe demonstrate our approach with a re-analysis of the SEAQUAMAT trial. We find no evidence for any crossover subgroup who would benefit from a change in treatment from the current standard-of-care, artesunate, but strong evidence for significant noncrossover TEH within the artesunate treatment group. We find that artesunate provides a differential benefit to patients with high numbers of circulating ring stage parasites.\n\nConclusionsOur ML approach combined with the use of computational notebooks and version control can improve the robustness and transparency of RCT exploratory analyses. The methods allow researchers to apply the latest ML techniques safe in the knowledge that any declared associations are statistically significant at a user defined level.

bioinformatics

A general framework for predicting the transcriptomic consequences of non-coding variation

Genome wide association studies (GWASs) for complex traits have implicated thousands of genetic loci. Most GWAS-nominated variants lie in noncoding regions, complicating the systematic translation of these findings into functional understanding. Here, we leverage convolutional neural networks to assist in this challenge. Our computational framework, peaBrain, models the transcriptional machinery of a tissue as a two-stage process: first, predicting the mean tissue specific abundance of all genes and second, incorporating the transcriptomic consequences of genotype variation to predict individual abundance on a subject-by-subject basis. We demonstrate that peaBrain accounts for the majority (>50%) of variance observed in mean transcript abundance across most tissues and outperforms regularized linear models in predicting the consequences of individual genotype variation. We highlight the validity of the peaBrain model by calculating non-coding impact scores that correlate with nucleotide evolutionary constraint that are also predictive of disease-associated variation and allele-specific transcription factor binding. We further show how these tissue-specific peaBrain scores can be leveraged to pinpoint functional tissues underlying complex traits, outperforming methods that depend on colocalization of eQTL and GWAS signals. We subsequently derive continuous dense embeddings of genes for downstream applications, and identify putatively functional eQTLs that are missed by high-throughput experimental approaches.

genetics

Transcriptome Deconvolution of Heterogeneous Tumor Samples with Immune Infiltration

Transcriptomic deconvolution in cancer and other heterogeneous tissues remains challenging. Available methods lack the ability to estimate both component-specific proportions and expression profiles for individual samples. We present DeMixT, a new tool to deconvolve high dimensional data from mixtures of more than two components. DeMixT implements an iterated conditional mode algorithm and a novel gene-set-based component merging approach to improve accuracy. In a series of experimental validation studies and application to TCGA data, DeMixT showed high accuracy. Improved deconvolution is an important step towards linking tumor transcriptomic data with clinical outcomes. An R package, scripts and data are available: https://github.com/wwylab/DeMixT/.

bioinformatics